LIRAGLUTIDE

LIRAGLUTIDE was reported 49687 times

LIRAGLUTIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PULMONARY VASCULITIS 154 0.2862
1 TOTAL LUNG CAPACITY ABNORMAL 111 0.2853
2 CAPILLARITIS 58 0.2101
3 SPIROMETRY ABNORMAL 107 0.1789
4 MITE ALLERGY 113 0.1725
5 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 96 0.1310
6 MYCOTIC ALLERGY 110 0.1287
7 MEDULLARY THYROID CANCER 42 0.1235
8 DUST ALLERGY 112 0.1142
9 NEURITIS 160 0.1036
10 PANCREATIC CARCINOMA METASTATIC 283 0.0994
11 WEIGHT LOSS POOR 478 0.0934
12 ADENOCARCINOMA PANCREAS 118 0.0918
13 PRODUCT CONTAMINATION WITH BODY FLUID 16 0.0780
14 CONJUNCTIVITIS ALLERGIC 114 0.0769
15 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 147 0.0720
16 LACK OF SATIETY 17 0.0651
17 RESPIRATORY SYMPTOM 154 0.0541
18 GASTROINTESTINAL HYPOMOTILITY 120 0.0532
19 DRUG DOSE TITRATION NOT PERFORMED 97 0.0529
20 GASTRIC HYPOMOTILITY 16 0.0521
21 CYCLIC VOMITING SYNDROME 38 0.0519
22 PAPILLARY THYROID CANCER 90 0.0517
23 IMPAIRED GASTRIC EMPTYING 654 0.0479
24 PANCREATITIS 2332 0.0441
25 GLYCOSYLATED HAEMOGLOBIN DECREASED 71 0.0441
26 FORCED EXPIRATORY VOLUME DECREASED 116 0.0409
27 ERUCTATION 767 0.0396
28 NORMOCHROMIC NORMOCYTIC ANAEMIA 117 0.0389
29 LIPASE INCREASED 283 0.0369
30 PANCREATIC PSEUDOCYST 28 0.0361
31 PANCREATIC NEUROENDOCRINE TUMOUR 23 0.0359
32 BENIGN NEOPLASM OF THYROID GLAND 25 0.0341
33 PANCREATIC NEOPLASM 42 0.0339
34 DIABETIC METABOLIC DECOMPENSATION 47 0.0338
35 RESPIRATORY TRACT HAEMORRHAGE 20 0.0335
36 PANCREATITIS ACUTE 742 0.0330
37 PANCREATIC CARCINOMA 945 0.0327
38 PANCREATIC MASS 34 0.0318
39 OBSTRUCTIVE PANCREATITIS 24 0.0314
40 PANCREATIC ENZYMES INCREASED 44 0.0300
41 NEUROLOGICAL SYMPTOM 166 0.0290
42 GLYCOSYLATED HAEMOGLOBIN INCREASED 725 0.0287
43 THYROID MASS 110 0.0286
44 THYROID NEOPLASM 79 0.0286
45 HYPOGLYCAEMIC UNCONSCIOUSNESS 56 0.0283
46 PULMONARY ALVEOLAR HAEMORRHAGE 158 0.0281
47 INJECTION SITE HAEMATOMA 362 0.0249
48 PANCREATITIS CHRONIC 59 0.0249
49 DIABETES MELLITUS INADEQUATE CONTROL 440 0.0248
50 PANCREATIC CYST 47 0.0246
51 BLOOD GLUCOSE DECREASED 1148 0.0239
52 AMYLASE INCREASED 88 0.0238
53 PANCREATITIS NECROTISING 54 0.0235
54 DIABETIC RETINOPATHY 77 0.0226
55 GALLBLADDER INJURY 42 0.0215
56 DIABETIC KETOACIDOSIS 513 0.0213
57 BLOOD AMYLASE INCREASED 36 0.0210
58 DRUG TITRATION ERROR 54 0.0209
59 BLOOD GLUCOSE INCREASED 3919 0.0208
60 BILIARY COLIC 60 0.0206
61 FOOD CRAVING 107 0.0203
62 BLOOD GLUCOSE FLUCTUATION 221 0.0201
63 ARTERIOSCLEROSIS CORONARY ARTERY 133 0.0201
64 BODY MASS INDEX INCREASED 27 0.0200
65 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 21 0.0198
66 KETOSIS 21 0.0194
67 HUNGER 269 0.0193
68 INSULIN RESISTANCE 40 0.0192
69 EUGLYCAEMIC DIABETIC KETOACIDOSIS 75 0.0181
70 INCREASED APPETITE 339 0.0177
71 CHOLANGIOCARCINOMA 26 0.0174
72 CAROTID ARTERIOSCLEROSIS 18 0.0174
73 OBSTRUCTIVE AIRWAYS DISORDER 194 0.0174
74 FOOD AVERSION 29 0.0171
75 METABOLIC SURGERY 19 0.0167
76 FULL BLOOD COUNT ABNORMAL 174 0.0164
77 CORRECTIVE LENS USER 16 0.0164
78 EARLY SATIETY 31 0.0159
79 NECK MASS 45 0.0159
80 ARTERIOSCLEROSIS 142 0.0151
81 GOITRE 61 0.0149
82 VOMITING PROJECTILE 43 0.0149
83 DIABETIC NEUROPATHY 73 0.0147
84 VASCULITIS 164 0.0141
85 HYPERPARATHYROIDISM SECONDARY 35 0.0140
86 BREATH ODOUR 34 0.0139
87 CHOLELITHIASIS 446 0.0136
88 THYROID CANCER 156 0.0129
89 KETOACIDOSIS 96 0.0128
90 INCORRECT STORAGE OF DRUG 22 0.0127
91 URINE KETONE BODY PRESENT 20 0.0127
92 GASTRIC DILATATION 20 0.0120
93 NODULE 156 0.0119
94 CHOLECYSTITIS 141 0.0118
95 BILE DUCT STONE 37 0.0116
96 CHOLECYSTECTOMY 130 0.0114
97 BLADDER TRANSITIONAL CELL CARCINOMA 16 0.0112
98 PANCREATIC DISORDER 55 0.0112
99 PANCREATIC CARCINOMA STAGE IV 35 0.0111
100 BLOOD GLUCOSE ABNORMAL 202 0.0109
101 NEPHROGENIC ANAEMIA 50 0.0108
102 INJECTION SITE URTICARIA 256 0.0104
103 ESSENTIAL HYPERTENSION 19 0.0104
104 FLATULENCE 577 0.0102
105 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 171 0.0101
106 SUPRAVENTRICULAR EXTRASYSTOLES 34 0.0101
107 HYPOGLYCAEMIA 487 0.0100
108 METABOLIC ALKALOSIS 16 0.0100
109 HICCUPS 80 0.0097
110 HYPERCHLORHYDRIA 57 0.0097
111 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 19 0.0096
112 INJECTION SITE HYPERSENSITIVITY 30 0.0096
113 INJECTION SITE RASH 287 0.0093
114 DEVICE MECHANICAL ISSUE 128 0.0093
115 DECREASED APPETITE 2123 0.0091
116 NAUSEA 7211 0.0091
117 PULMONARY FIBROSIS 174 0.0091
118 RECALLED PRODUCT ADMINISTERED 83 0.0087
119 ABNORMAL LOSS OF WEIGHT 59 0.0086
120 CHOLECYSTITIS ACUTE 49 0.0086
121 LACTIC ACIDOSIS 274 0.0085
122 REGURGITATION 29 0.0084
123 DEVICE FAILURE 128 0.0084
124 POTENTIATING DRUG INTERACTION 28 0.0083
125 APPETITE DISORDER 55 0.0083
126 RENAL MASS 17 0.0082
127 DYSPEPSIA 809 0.0082
128 INCORRECT PRODUCT STORAGE 108 0.0082
129 DIABETIC NEPHROPATHY 18 0.0082
130 INJECTION SITE NODULE 90 0.0082
131 DIABETIC FOOT 25 0.0082
132 ILEUS 101 0.0081
133 IRON DEFICIENCY 36 0.0080
134 HYPOTHYROIDISM 254 0.0079
135 METASTASES TO LIVER 139 0.0079
136 LISTLESS 26 0.0079
137 NECROTISING FASCIITIS 27 0.0077
138 WEIGHT DECREASED 2121 0.0076
139 CHOLECYSTITIS INFECTIVE 21 0.0076
140 VOMITING 3545 0.0075
141 CONSTIPATION 1630 0.0075
142 POSTMENOPAUSAL HAEMORRHAGE 19 0.0073
143 BLOOD PRESSURE SYSTOLIC ABNORMAL 18 0.0073
144 REBOUND ACID HYPERSECRETION 22 0.0073
145 GASTROOESOPHAGEAL REFLUX DISEASE 583 0.0072
146 OPTIC ISCHAEMIC NEUROPATHY 28 0.0072
147 FUNCTIONAL GASTROINTESTINAL DISORDER 25 0.0072
148 ABDOMINAL PAIN UPPER 1477 0.0072
149 HEPATIC STEATOSIS 133 0.0071
150 JAUNDICE CHOLESTATIC 25 0.0071
151 DEVICE DEFECTIVE 122 0.0070
152 GALLBLADDER OPERATION 28 0.0069
153 CATARACT OPERATION 41 0.0069
154 TOE AMPUTATION 35 0.0069
155 INJECTION SITE PRURITUS 454 0.0068
156 METASTASES TO PERITONEUM 17 0.0067
157 ABDOMINAL DISTENSION 701 0.0067
158 DEVICE MALFUNCTION 459 0.0065
159 HAEMOPTYSIS 182 0.0065
160 INFREQUENT BOWEL MOVEMENTS 16 0.0064
161 PYELONEPHRITIS 55 0.0063
162 BLADDER PAIN 20 0.0063
163 BOWEL MOVEMENT IRREGULARITY 48 0.0063
164 DEHYDRATION 828 0.0062
165 TRIGGER FINGER 25 0.0061
166 ABDOMINAL DISCOMFORT 1026 0.0061
167 UMBILICAL HERNIA 28 0.0060
168 HYPERGLYCAEMIA 217 0.0059
169 URINE ODOUR ABNORMAL 35 0.0059
170 ENERGY INCREASED 35 0.0059
171 GASTROINTESTINAL SOUNDS ABNORMAL 29 0.0058
172 GLOMERULAR FILTRATION RATE DECREASED 70 0.0057
173 SKIN HYPERTROPHY 16 0.0057
174 MENISCUS INJURY 35 0.0057
175 ABDOMINAL PAIN 1314 0.0056
176 CHRONIC KIDNEY DISEASE 428 0.0056
177 INJECTION SITE VESICLES 34 0.0056
178 WEIGHT INCREASED 1256 0.0056
179 EXTRASYSTOLES 39 0.0056
180 GASTRITIS 147 0.0056
181 VASCULAR GRAFT 16 0.0055
182 GALLBLADDER DISORDER 99 0.0055
183 HYPERPHAGIA 22 0.0055
184 GASTROINTESTINAL NECROSIS 16 0.0055
185 METASTASES TO LYMPH NODES 37 0.0055
186 DRUG LEVEL ABOVE THERAPEUTIC 25 0.0055
187 END STAGE RENAL DISEASE 98 0.0054
188 VULVOVAGINAL PRURITUS 27 0.0053
189 PRODUCT COMMUNICATION ISSUE 47 0.0053
190 ACUTE KIDNEY INJURY 814 0.0053
191 INJECTION SITE BRUISING 424 0.0053
192 INJECTION SITE REACTION 365 0.0053
193 AUTOIMMUNE THYROIDITIS 20 0.0053
194 DIARRHOEA 3409 0.0053
195 INJECTION SITE EXTRAVASATION 64 0.0052
196 MALNUTRITION 58 0.0052
197 GASTROENTERITIS 75 0.0051
198 INJECTION SITE MASS 189 0.0051
199 RETINOPATHY 19 0.0051
200 GASTROINTESTINAL PAIN 56 0.0051
201 ANXIETY DISORDER 17 0.0051
202 PRURITUS GENERALISED 110 0.0051
203 VULVOVAGINAL MYCOTIC INFECTION 20 0.0051
204 SKIN ODOUR ABNORMAL 20 0.0051
205 INJECTION SITE DISCOLOURATION 63 0.0050
206 DIVERTICULUM INTESTINAL 22 0.0050
207 MOUTH SWELLING 29 0.0050
208 HEPATIC ENZYME ABNORMAL 25 0.0050
209 RENAL PAIN 53 0.0050
210 PAROSMIA 37 0.0049
211 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 20 0.0049
212 RETCHING 104 0.0049
213 FOOD POISONING 26 0.0048
214 URINE ABNORMALITY 22 0.0048
215 ABDOMINAL HERNIA 22 0.0048
216 DEVICE DELIVERY SYSTEM ISSUE 132 0.0048
217 WEIGHT FLUCTUATION 50 0.0048
218 ACCIDENTAL UNDERDOSE 68 0.0047
219 STENT PLACEMENT 38 0.0047
220 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 18 0.0047
221 INJECTION SITE ERYTHEMA 584 0.0047
222 ILEUS PARALYTIC 21 0.0047
223 VITAMIN B12 DEFICIENCY 19 0.0047
224 PRODUCT COLOUR ISSUE 24 0.0047
225 SLEEP APNOEA SYNDROME 89 0.0047
226 DEVICE OPERATIONAL ISSUE 20 0.0046
227 FOOD INTOLERANCE 17 0.0046
228 LARGE INTESTINE POLYP 32 0.0046
229 HYPERLIPIDAEMIA 55 0.0046
230 DISABILITY 91 0.0046
231 CORONARY ARTERY OCCLUSION 63 0.0046
232 THIRST 82 0.0046
233 SOMNAMBULISM 30 0.0046
234 INCORRECT DOSE ADMINISTERED BY DEVICE 119 0.0045
235 RENAL CYST 36 0.0045
236 INJECTION SITE HAEMORRHAGE 362 0.0045
237 DYSGEUSIA 336 0.0045
238 INTESTINAL OBSTRUCTION 170 0.0045
239 BLOOD TRIGLYCERIDES INCREASED 79 0.0045
240 FUNGAL INFECTION 149 0.0045
241 BENIGN PROSTATIC HYPERPLASIA 23 0.0044
242 POLLAKIURIA 184 0.0044
243 NEPHROPATHY 41 0.0044
244 HYPOVOLAEMIC SHOCK 21 0.0044
245 BLOOD LACTIC ACID INCREASED 23 0.0044
246 DIVERTICULUM 31 0.0044
247 CHOLANGITIS 27 0.0044
248 BLOOD CALCIUM INCREASED 38 0.0043
249 PROSTATOMEGALY 17 0.0043
250 HAEMORRHAGIC ANAEMIA 19 0.0043
251 COLD SWEAT 76 0.0043
252 ANURIA 37 0.0043
253 FEELING OF DESPAIR 20 0.0043
254 HYPERTRIGLYCERIDAEMIA 25 0.0043
255 GASTROENTERITIS VIRAL 77 0.0043
256 LUNG DISORDER 209 0.0043
257 HYPOXIA 149 0.0042
258 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 202 0.0042
259 CARDIAC OPERATION 36 0.0042
260 SUBCUTANEOUS ABSCESS 20 0.0042
261 APHAGIA 20 0.0042
262 SENSATION OF FOREIGN BODY 35 0.0041
263 FEELING OF BODY TEMPERATURE CHANGE 24 0.0041
264 APPENDICITIS 38 0.0041
265 BLOOD MAGNESIUM DECREASED 35 0.0041
266 NEPHROLITHIASIS 185 0.0040
267 COLITIS ISCHAEMIC 27 0.0040
268 FEELING JITTERY 76 0.0040
269 RASH GENERALISED 102 0.0039
270 HEPATIC LESION 17 0.0039
271 HYPOVOLAEMIA 23 0.0039
272 WHEEZING 233 0.0039
273 ACIDOSIS 30 0.0039
274 CATARACT 230 0.0039
275 PRE-EXISTING CONDITION IMPROVED 24 0.0038
276 UTERINE LEIOMYOMA 28 0.0038
277 GANGRENE 23 0.0038
278 URINE OUTPUT DECREASED 33 0.0038
279 PRODUCTIVE COUGH 180 0.0038
280 SPINAL OPERATION 46 0.0037
281 OBESITY 59 0.0037
282 LIQUID PRODUCT PHYSICAL ISSUE 27 0.0037
283 FEEDING DISORDER 75 0.0037
284 RENAL FAILURE 487 0.0037
285 POLYURIA 30 0.0037
286 METASTASES TO LUNG 42 0.0036
287 INJECTION SITE INFLAMMATION 18 0.0036
288 RETINAL DETACHMENT 33 0.0036
289 CHOLECYSTITIS CHRONIC 24 0.0036
290 MEDICATION RESIDUE PRESENT 17 0.0036
291 LIMB OPERATION 17 0.0035
292 HYPERKALAEMIA 124 0.0035
293 INJECTION SITE IRRITATION 45 0.0035
294 SLUGGISHNESS 36 0.0035
295 ANAL ABSCESS 19 0.0035
296 FACIAL PARALYSIS 30 0.0035
297 THYROID DISORDER 54 0.0035
298 TYPE 1 DIABETES MELLITUS 21 0.0035
299 CORONARY ARTERY BYPASS 20 0.0035
300 RENAL CELL CARCINOMA 17 0.0035
301 LYMPHOEDEMA 24 0.0035
302 DIVERTICULITIS 96 0.0035
303 HYSTERECTOMY 30 0.0035
304 BLOOD CHOLESTEROL ABNORMAL 16 0.0035
305 KNEE OPERATION 34 0.0035
306 INTESTINAL ISCHAEMIA 19 0.0034
307 RENAL FUNCTION TEST ABNORMAL 16 0.0034
308 CARPAL TUNNEL SYNDROME 48 0.0034
309 INJECTION SITE INJURY 19 0.0034
310 SMALL INTESTINAL OBSTRUCTION 42 0.0034
311 METABOLIC ACIDOSIS 109 0.0034
312 VISUAL IMPAIRMENT 422 0.0034
313 LOWER GASTROINTESTINAL HAEMORRHAGE 25 0.0034
314 MENSTRUAL DISORDER 28 0.0034
315 HYPERHIDROSIS 435 0.0034
316 WRONG DRUG ADMINISTERED 30 0.0034
317 KIDNEY INFECTION 66 0.0034
318 HEART RATE INCREASED 333 0.0034
319 RENAL FAILURE ACUTE 142 0.0033
320 LIGAMENT SPRAIN 33 0.0033
321 VENTRICULAR FIBRILLATION 37 0.0033
322 GASTROINTESTINAL DISORDER 298 0.0033
323 HYPERCHOLESTEROLAEMIA 32 0.0033
324 DIZZINESS POSTURAL 32 0.0033
325 PRESYNCOPE 80 0.0033
326 HYPERVENTILATION 19 0.0033
327 FOOT FRACTURE 62 0.0033
328 CELLULITIS 164 0.0033
329 HEADACHE 2036 0.0032
330 POLYARTHRITIS 17 0.0032
331 ABDOMINAL TENDERNESS 16 0.0032
332 EAR DISCOMFORT 33 0.0032
333 FLANK PAIN 30 0.0032
334 BLOOD URINE PRESENT 60 0.0032
335 GINGIVITIS 17 0.0031
336 MALAISE 1378 0.0031
337 SUDDEN DEATH 33 0.0031
338 BLOOD TESTOSTERONE DECREASED 21 0.0031
339 DIZZINESS 1530 0.0031
340 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 218 0.0031
341 INJURY ASSOCIATED WITH DEVICE 62 0.0030
342 JOINT INJURY 65 0.0030
343 HAIR DISORDER 25 0.0030
344 RENAL INJURY 90 0.0030
345 DYSPHONIA 177 0.0030
346 INTENTIONAL UNDERDOSE 22 0.0030
347 SCIATICA 48 0.0030
348 ASTHMA 338 0.0030
349 VITAMIN D DEFICIENCY 29 0.0030
350 GOUT 53 0.0030
351 DIABETES MELLITUS 225 0.0029
352 MASS 41 0.0029
353 NECK PAIN 163 0.0029
354 ANKLE FRACTURE 45 0.0029
355 BACK PAIN 675 0.0029
356 KNEE ARTHROPLASTY 61 0.0029
357 RENAL DISORDER 135 0.0029
358 ANAL INCONTINENCE 26 0.0029
359 DIARRHOEA HAEMORRHAGIC 27 0.0029
360 WALKING AID USER 19 0.0029
361 FEELING COLD 80 0.0029
362 PRODUCT ODOUR ABNORMAL 30 0.0029
363 PALPITATIONS 335 0.0029
364 PHARYNGEAL OEDEMA 44 0.0029
365 OSTEOARTHRITIS 121 0.0029
366 INJECTION SITE DISCOMFORT 30 0.0028
367 MACULAR DEGENERATION 34 0.0028
368 DRY MOUTH 231 0.0028
369 POST-TRAUMATIC STRESS DISORDER 19 0.0028
370 TUBULOINTERSTITIAL NEPHRITIS 53 0.0028
371 BLOOD POTASSIUM DECREASED 85 0.0028
372 BLOOD THYROID STIMULATING HORMONE INCREASED 26 0.0028
373 LIVER FUNCTION TEST ABNORMAL 82 0.0028
374 HAEMORRHAGIC STROKE 22 0.0028
375 PRODUCT ADMINISTRATION INTERRUPTED 22 0.0028
376 MICTURITION URGENCY 32 0.0028
377 GASTROINTESTINAL INFECTION 25 0.0028
378 HIATUS HERNIA 36 0.0028
379 INJECTION SITE PAIN 852 0.0028
380 EATING DISORDER 59 0.0028
381 CYSTITIS 88 0.0028
382 ACCIDENT 33 0.0028
383 PHARYNGEAL SWELLING 27 0.0028
384 DRY THROAT 28 0.0028
385 COLON CANCER 41 0.0027
386 UTERINE CANCER 22 0.0027
387 IRON DEFICIENCY ANAEMIA 25 0.0027
388 GLAUCOMA 52 0.0027
389 INJECTION SITE INDURATION 35 0.0027
390 SKIN REACTION 38 0.0027
391 BLOOD IRON DECREASED 32 0.0027
392 ASTHENIA 1010 0.0027
393 NERVOUSNESS 140 0.0027
394 LETHARGY 154 0.0027
395 FAECES DISCOLOURED 58 0.0027
396 CORONARY ARTERY DISEASE 81 0.0027
397 TRANSIENT ISCHAEMIC ATTACK 90 0.0027
398 SURGERY 156 0.0027
399 INTERVERTEBRAL DISC PROTRUSION 58 0.0027
400 APHONIA 37 0.0026
401 OSTEOMYELITIS 48 0.0026
402 RENAL TUBULAR NECROSIS 26 0.0026
403 BLOOD POTASSIUM INCREASED 43 0.0026
404 CLOSTRIDIUM DIFFICILE COLITIS 28 0.0026
405 THROAT TIGHTNESS 71 0.0026
406 ANGINA UNSTABLE 17 0.0026
407 MUSCULOSKELETAL DISCOMFORT 45 0.0026
408 SUPRAVENTRICULAR TACHYCARDIA 25 0.0026
409 NEEDLE ISSUE 76 0.0026
410 HEPATIC CIRRHOSIS 49 0.0026
411 POLYP 17 0.0026
412 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 16 0.0026
413 BLOOD PRESSURE DECREASED 172 0.0026
414 AUTOIMMUNE HEPATITIS 18 0.0026
415 BACK DISORDER 42 0.0026
416 HYPOPHAGIA 66 0.0026
417 LOCAL SWELLING 45 0.0026
418 GASTRIC ULCER 49 0.0026
419 HEPATIC ENCEPHALOPATHY 24 0.0026
420 ROTATOR CUFF SYNDROME 33 0.0026
421 IRRITABLE BOWEL SYNDROME 55 0.0026
422 HAEMATEMESIS 65 0.0026
423 PRODUCT QUALITY ISSUE 348 0.0026
424 LIP SWELLING 85 0.0025
425 HIP ARTHROPLASTY 39 0.0025
426 HEPATOMEGALY 25 0.0025
427 ACUTE MYOCARDIAL INFARCTION 75 0.0025
428 THROMBOSIS 204 0.0025
429 BREAST MASS 17 0.0025
430 FURUNCLE 20 0.0025
431 DRUG DOSE OMISSION 414 0.0025
432 SALIVARY HYPERSECRETION 25 0.0025
433 MADAROSIS 29 0.0025
434 VISION BLURRED 343 0.0025
435 URINARY INCONTINENCE 74 0.0025
436 PARAESTHESIA ORAL 36 0.0025
437 HAIR COLOUR CHANGES 31 0.0025
438 ANXIETY 707 0.0025
439 ATELECTASIS 24 0.0025
440 DEPRESSION 565 0.0025
441 BLINDNESS UNILATERAL 35 0.0025
442 HYPOKALAEMIA 114 0.0025
443 FIBROMYALGIA 60 0.0025
444 BLOOD CREATININE INCREASED 161 0.0025
445 COVID-19 PNEUMONIA 29 0.0025
446 JAUNDICE 66 0.0025
447 ULCER 39 0.0024
448 ACUTE RESPIRATORY FAILURE 47 0.0024
449 RENAL IMPAIRMENT 205 0.0024
450 HYPERAESTHESIA 20 0.0024
451 SWOLLEN TONGUE 76 0.0024
452 MULTIPLE ALLERGIES 19 0.0024
453 DYSURIA 89 0.0024
454 URINARY TRACT INFECTION 411 0.0024
455 VENTRICULAR EXTRASYSTOLES 25 0.0024
456 MUSCLE SPASMS 441 0.0024
457 COLITIS 91 0.0024
458 HAND FRACTURE 17 0.0024
459 SKIN ULCER 62 0.0024
460 ATRIAL FIBRILLATION 233 0.0024
461 MUSCULOSKELETAL CHEST PAIN 37 0.0024
462 RETINAL HAEMORRHAGE 17 0.0024
463 INTERVERTEBRAL DISC DEGENERATION 22 0.0024
464 TASTE DISORDER 48 0.0024
465 DISCOMFORT 144 0.0024
466 SYNCOPE 236 0.0024
467 FRUSTRATION TOLERANCE DECREASED 19 0.0023
468 PULMONARY EMBOLISM 223 0.0023
469 HEPATITIS 60 0.0023
470 NERVE INJURY 26 0.0023
471 URTICARIA 391 0.0023
472 AGEUSIA 58 0.0023
473 EYE HAEMORRHAGE 31 0.0023
474 PROSTATIC SPECIFIC ANTIGEN INCREASED 32 0.0023
475 POOR QUALITY SLEEP 50 0.0023
476 ABNORMAL FAECES 19 0.0023
477 HAIR TEXTURE ABNORMAL 31 0.0023
478 PSYCHOLOGICAL TRAUMA 20 0.0023
479 GASTROINTESTINAL CARCINOMA 21 0.0023
480 HAEMORRHOIDS 45 0.0023
481 NOCTURIA 28 0.0023
482 UPPER-AIRWAY COUGH SYNDROME 19 0.0023
483 PHOTOSENSITIVITY REACTION 38 0.0023
484 FEELING HOT 141 0.0023
485 CEREBRAL DISORDER 17 0.0023
486 IMPAIRED QUALITY OF LIFE 33 0.0023
487 LOSS OF CONSCIOUSNESS 294 0.0023
488 ARTHROPOD BITE 17 0.0023
489 MUSCLE ATROPHY 29 0.0023
490 PRODUCT USE COMPLAINT 36 0.0023
491 ANGIOEDEMA 101 0.0023
492 HYPERTHYROIDISM 33 0.0023
493 SCAR 39 0.0023
494 SCRATCH 24 0.0023
495 HYPERCALCAEMIA 28 0.0023
496 SEASONAL ALLERGY 32 0.0023
497 HEAD DISCOMFORT 40 0.0023
498 TOOTH ABSCESS 23 0.0023
499 AUTOIMMUNE DISORDER 22 0.0023
500 MIGRAINE 215 0.0022
501 ROAD TRAFFIC ACCIDENT 94 0.0022
502 INTENTIONAL DOSE OMISSION 64 0.0022
503 DRUG-INDUCED LIVER INJURY 70 0.0022
504 BLOOD CHOLESTEROL INCREASED 104 0.0022
505 TEMPERATURE INTOLERANCE 23 0.0022
506 SLEEP DISORDER 157 0.0022
507 HERNIA 43 0.0022
508 LIMB INJURY 60 0.0022
509 PRODUCT USE ISSUE 415 0.0022
510 BACK INJURY 24 0.0022
511 INJECTION SITE SWELLING 169 0.0022
512 CHEST PAIN 408 0.0022
513 ARTHRITIS 173 0.0022
514 CONCUSSION 17 0.0022
515 TREMOR 364 0.0022
516 INFLUENZA 244 0.0022
517 HEPATOCELLULAR INJURY 31 0.0022
518 FEELING ABNORMAL 523 0.0022
519 ORTHOSTATIC HYPOTENSION 38 0.0022
520 CONDITION AGGRAVATED 663 0.0022
521 BLOOD PRESSURE INCREASED 333 0.0022
522 OFF LABEL USE 1905 0.0022
523 LYMPHADENOPATHY 77 0.0022
524 GROIN PAIN 19 0.0022
525 DEVICE ISSUE 194 0.0022
526 ARTERIAL OCCLUSIVE DISEASE 17 0.0022
527 SPINAL OSTEOARTHRITIS 19 0.0022
528 ALOPECIA 424 0.0022
529 FATIGUE 1678 0.0022
530 PULMONARY MASS 32 0.0021
531 SINUS CONGESTION 29 0.0021
532 PAIN IN EXTREMITY 631 0.0021
533 GASTRIC DISORDER 73 0.0021
534 INFLUENZA LIKE ILLNESS 175 0.0021
535 PERIPHERAL SWELLING 327 0.0021
536 TACHYCARDIA 187 0.0021
537 MYASTHENIA GRAVIS 17 0.0021
538 EAR INFECTION 56 0.0021
539 ERECTILE DYSFUNCTION 54 0.0021
540 EXTRA DOSE ADMINISTERED 85 0.0021
541 DYSPNOEA EXERTIONAL 79 0.0021
542 OROPHARYNGEAL PAIN 193 0.0021
543 EXOSTOSIS 19 0.0021
544 BRONCHITIS 154 0.0021
545 LOCALISED INFECTION 50 0.0021
546 SOMNOLENCE 416 0.0021
547 FLUID RETENTION 105 0.0021
548 ABDOMINAL PAIN LOWER 52 0.0021
549 RASH PRURITIC 111 0.0020
550 HYPOACUSIS 88 0.0020
551 BLOOD PRESSURE FLUCTUATION 49 0.0020
552 ADVERSE REACTION 27 0.0020
553 NEUROPATHY PERIPHERAL 193 0.0020
554 DRUG INTERACTION 320 0.0020
555 SKIN PLAQUE 17 0.0020
556 CONTUSION 194 0.0020
557 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 361 0.0020
558 VERTIGO 122 0.0020
559 HEPATIC ENZYME INCREASED 136 0.0020
560 NASAL CONGESTION 117 0.0020
561 HYPOAESTHESIA ORAL 30 0.0020
562 EMOTIONAL DISTRESS 240 0.0020
563 NO ADVERSE EVENT 358 0.0020
564 TOOTH INFECTION 26 0.0020
565 UPPER RESPIRATORY TRACT INFECTION 91 0.0020
566 WOUND 55 0.0020
567 CEREBRAL INFARCTION 48 0.0020
568 ARRHYTHMIA 93 0.0020
569 SUBARACHNOID HAEMORRHAGE 20 0.0020
570 INTESTINAL PERFORATION 22 0.0020
571 HYPERSOMNIA 56 0.0020
572 OVARIAN CANCER 18 0.0020
573 ILLNESS 201 0.0019
574 EYE INFECTION 22 0.0019
575 SPINAL FRACTURE 39 0.0019
576 TENDON RUPTURE 24 0.0019
577 LIMB DISCOMFORT 60 0.0019
578 LEUKOCYTOSIS 35 0.0019
579 CYST 24 0.0019
580 ACUTE CORONARY SYNDROME 16 0.0019
581 HYPOKINESIA 28 0.0019
582 VISUAL ACUITY REDUCED 64 0.0019
583 VIRAL INFECTION 64 0.0019
584 INCORRECT DOSE ADMINISTERED 439 0.0019
585 TENDERNESS 20 0.0019
586 CARDIAC FAILURE CONGESTIVE 154 0.0019
587 INSOMNIA 509 0.0019
588 DERMATITIS ALLERGIC 24 0.0019
589 UPPER LIMB FRACTURE 38 0.0019
590 SPUTUM DISCOLOURED 18 0.0019
591 PRODUCT PACKAGING ISSUE 18 0.0019
592 HYPERTENSION 401 0.0019
593 INCONTINENCE 20 0.0019
594 DEVICE LEAKAGE 82 0.0019
595 BLINDNESS 77 0.0019
596 FALL 628 0.0019
597 DYSPNOEA 1063 0.0019
598 HYPOTHERMIA 19 0.0019
599 INTENTIONAL PRODUCT USE ISSUE 164 0.0019
600 ABORTION SPONTANEOUS 75 0.0019
601 TYPE 2 DIABETES MELLITUS 63 0.0019
602 CARDIAC DISORDER 175 0.0019
603 SINUS DISORDER 37 0.0019
604 HYPOMAGNESAEMIA 26 0.0019
605 EYE DISORDER 61 0.0019
606 PROTEINURIA 35 0.0018
607 SKIN LACERATION 20 0.0018
608 UNDERDOSE 134 0.0018
609 SUICIDAL IDEATION 168 0.0018
610 DYSPHAGIA 174 0.0018
611 URINARY RETENTION 61 0.0018
612 THERAPEUTIC RESPONSE UNEXPECTED 82 0.0018
613 CHILLS 214 0.0018
614 INTERNATIONAL NORMALISED RATIO INCREASED 52 0.0018
615 HYPERSENSITIVITY 337 0.0018
616 INABILITY TO AFFORD MEDICATION 18 0.0018
617 BURNING SENSATION 127 0.0018
618 TENDONITIS 28 0.0018
619 ELECTROLYTE IMBALANCE 21 0.0018
620 CHEST DISCOMFORT 185 0.0018
621 SWELLING 169 0.0018
622 THROAT IRRITATION 81 0.0018
623 EYE SWELLING 67 0.0018
624 INJECTION SITE WARMTH 37 0.0018
625 HYPERTENSIVE CRISIS 20 0.0018
626 PRODUCT DISPENSING ERROR 39 0.0018
627 BALANCE DISORDER 154 0.0018
628 HEAVY MENSTRUAL BLEEDING 16 0.0018
629 CHROMATURIA 40 0.0018
630 CHOLESTASIS 34 0.0018
631 DRUG PRESCRIBING ERROR 34 0.0018
632 AFFECT LABILITY 17 0.0018
633 ARTHROPATHY 98 0.0018
634 DRUG DOSE OMISSION BY DEVICE 138 0.0018
635 SINUS TACHYCARDIA 25 0.0018
636 RESTLESS LEGS SYNDROME 32 0.0018
637 MYOCARDIAL ISCHAEMIA 20 0.0018
638 HAEMATURIA 60 0.0018
639 RIB FRACTURE 36 0.0017
640 PERIPHERAL COLDNESS 24 0.0017
641 ALANINE AMINOTRANSFERASE INCREASED 107 0.0017
642 MYALGIA 296 0.0017
643 SEPSIS 194 0.0017
644 OESOPHAGITIS 19 0.0017
645 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 90 0.0017
646 PRODUCT PRESCRIBING ERROR 41 0.0017
647 PRODUCT USE IN UNAPPROVED INDICATION 426 0.0017
648 MUSCULAR WEAKNESS 195 0.0017
649 CEREBROVASCULAR ACCIDENT 290 0.0017
650 BLOOD PRESSURE SYSTOLIC INCREASED 33 0.0017
651 LIVER DISORDER 75 0.0017
652 MUSCULOSKELETAL PAIN 88 0.0017
653 GAIT INABILITY 56 0.0017
654 PSORIATIC ARTHROPATHY 68 0.0017
655 THERAPY CESSATION 86 0.0017
656 BLOOD UREA INCREASED 28 0.0017
657 ORAL CANDIDIASIS 22 0.0017
658 PRODUCT DOSE OMISSION 109 0.0017
659 INTENTIONAL PRODUCT MISUSE 146 0.0017
660 ACCIDENTAL OVERDOSE 61 0.0017
661 DRUG INTOLERANCE 161 0.0017
662 HYPOTENSION 334 0.0017
663 MYOCARDIAL INFARCTION 290 0.0017
664 RASH 722 0.0017
665 DEVICE BREAKAGE 67 0.0016
666 SINUSITIS 169 0.0016
667 HAEMATOCHEZIA 91 0.0016
668 BONE DISORDER 30 0.0016
669 DEPRESSED MOOD 87 0.0016
670 POOR VENOUS ACCESS 17 0.0016
671 PARKINSONISM 16 0.0016
672 PRURITUS 627 0.0016
673 IRRITABILITY 98 0.0016
674 NASOPHARYNGITIS 300 0.0016
675 THERAPY CHANGE 16 0.0016
676 OEDEMA PERIPHERAL 198 0.0016
677 MEMORY IMPAIRMENT 223 0.0016
678 CARDIAC FAILURE 130 0.0016
679 LYMPHOMA 25 0.0016
680 VAGINAL HAEMORRHAGE 70 0.0016
681 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 326 0.0016
682 OXYGEN SATURATION DECREASED 90 0.0016
683 PULMONARY CONGESTION 21 0.0016
684 HOT FLUSH 120 0.0016
685 INTERNAL HAEMORRHAGE 18 0.0016
686 HOSPITALISATION 242 0.0016
687 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 27 0.0016
688 BLOOD ALKALINE PHOSPHATASE INCREASED 39 0.0016
689 INSURANCE ISSUE 24 0.0016
690 SWELLING FACE 102 0.0016
691 HERPES ZOSTER 90 0.0016
692 BURSITIS 19 0.0016
693 BIPOLAR DISORDER 17 0.0016
694 BLOOD CREATINE PHOSPHOKINASE INCREASED 45 0.0016
695 COVID-19 274 0.0016
696 RECTAL HAEMORRHAGE 67 0.0016
697 INITIAL INSOMNIA 16 0.0016
698 PRODUCT STORAGE ERROR 136 0.0016
699 PARAESTHESIA 241 0.0015
700 BRAIN FOG 24 0.0015
701 TINNITUS 70 0.0015
702 MULTIPLE ORGAN DYSFUNCTION SYNDROME 43 0.0015
703 FREQUENT BOWEL MOVEMENTS 41 0.0015
704 ILL-DEFINED DISORDER 92 0.0015
705 HEART RATE DECREASED 53 0.0015
706 THINKING ABNORMAL 28 0.0015
707 CONFUSIONAL STATE 242 0.0015
708 SKIN LESION 41 0.0015
709 GAMMA-GLUTAMYLTRANSFERASE INCREASED 33 0.0015
710 PHARYNGITIS STREPTOCOCCAL 16 0.0015
711 PRODUCT DOSE OMISSION ISSUE 434 0.0015
712 OEDEMA 80 0.0015
713 MOOD SWINGS 47 0.0015
714 ANAPHYLACTIC SHOCK 38 0.0015
715 ADVERSE DRUG REACTION 132 0.0015
716 ARTHRALGIA 611 0.0015
717 UNEVALUABLE EVENT 111 0.0015
718 HYPOAESTHESIA 219 0.0015
719 BLOOD PRESSURE ABNORMAL 29 0.0015
720 ISCHAEMIC STROKE 26 0.0015
721 CARDIAC ARREST 120 0.0015
722 SPLENOMEGALY 17 0.0014
723 ASPARTATE AMINOTRANSFERASE INCREASED 77 0.0014
724 AMNESIA 94 0.0014
725 EXPIRED PRODUCT ADMINISTERED 48 0.0014
726 LIVER FUNCTION TEST INCREASED 31 0.0014
727 DISORIENTATION 57 0.0014
728 ANGINA PECTORIS 41 0.0014
729 ANAPHYLACTIC REACTION 79 0.0014
730 SEPTIC SHOCK 62 0.0014
731 HEART RATE IRREGULAR 32 0.0014
732 RHABDOMYOLYSIS 59 0.0014
733 MITRAL VALVE INCOMPETENCE 16 0.0014
734 SKIN EXFOLIATION 119 0.0014
735 OSTEOPOROSIS 58 0.0014
736 RESPIRATORY DISORDER 42 0.0014
737 ADRENAL INSUFFICIENCY 17 0.0014
738 PREGNANCY 28 0.0014
739 PARALYSIS 20 0.0014
740 SPEECH DISORDER 73 0.0014
741 RHINORRHOEA 90 0.0014
742 SHOCK 32 0.0014
743 DEEP VEIN THROMBOSIS 90 0.0014
744 RESPIRATORY TRACT INFECTION 36 0.0014
745 TOOTHACHE 25 0.0014
746 BREAST CANCER 128 0.0014
747 DISTURBANCE IN ATTENTION 74 0.0014
748 SPINAL PAIN 16 0.0014
749 STAPHYLOCOCCAL INFECTION 45 0.0014
750 CANDIDA INFECTION 23 0.0014
751 ASCITES 40 0.0014
752 HEAD INJURY 43 0.0014
753 MUSCLE TIGHTNESS 22 0.0014
754 LOWER LIMB FRACTURE 26 0.0014
755 PAIN 831 0.0014
756 EJECTION FRACTION DECREASED 21 0.0013
757 EPISTAXIS 101 0.0013
758 DRUG EFFECT LESS THAN EXPECTED 20 0.0013
759 TRANSAMINASES INCREASED 30 0.0013
760 WRONG TECHNIQUE IN DRUG USAGE PROCESS 49 0.0013
761 COMA 64 0.0013
762 ENCEPHALOPATHY 33 0.0013
763 GASTROINTESTINAL HAEMORRHAGE 112 0.0013
764 DIALYSIS 19 0.0013
765 SNEEZING 30 0.0013
766 INFLAMMATION 69 0.0013
767 WRIST FRACTURE 16 0.0013
768 NIGHT SWEATS 43 0.0013
769 COUGH 374 0.0013
770 FLUSHING 135 0.0013
771 HEPATIC FAILURE 40 0.0013
772 BLADDER CANCER 78 0.0013
773 DEMENTIA 37 0.0013
774 DRUG EFFECT INCOMPLETE 48 0.0013
775 INFUSION SITE PAIN 17 0.0013
776 PSORIASIS 172 0.0013
777 GAIT DISTURBANCE 252 0.0013
778 CEREBRAL HAEMORRHAGE 47 0.0013
779 IMPAIRED WORK ABILITY 28 0.0013
780 DIPLOPIA 34 0.0013
781 UPPER GASTROINTESTINAL HAEMORRHAGE 22 0.0013
782 PRODUCT DOSE OMISSION IN ERROR 37 0.0013
783 HEMIPARESIS 22 0.0013
784 ORAL PAIN 29 0.0013
785 ALTERED STATE OF CONSCIOUSNESS 28 0.0013
786 HEPATIC CANCER 31 0.0013
787 NEOPLASM MALIGNANT 86 0.0013
788 MENTAL DISORDER 56 0.0013
789 BACTERIAL INFECTION 24 0.0013
790 CARDIOMYOPATHY 19 0.0013
791 MIDDLE INSOMNIA 24 0.0013
792 RESTLESSNESS 47 0.0013
793 MOOD ALTERED 35 0.0013
794 IMPAIRED HEALING 42 0.0013
795 HYPONATRAEMIA 72 0.0013
796 DYSARTHRIA 48 0.0013
797 NIGHTMARE 44 0.0013
798 CARDIO-RESPIRATORY ARREST 53 0.0013
799 MUSCULOSKELETAL STIFFNESS 111 0.0013
800 PANIC ATTACK 46 0.0013
801 PROCEDURAL PAIN 35 0.0013
802 BRONCHOSPASM 18 0.0013
803 TREATMENT NONCOMPLIANCE 69 0.0013
804 DEVICE USE ISSUE 22 0.0013
805 ABSCESS 20 0.0013
806 TACHYPNOEA 17 0.0012
807 MOBILITY DECREASED 89 0.0012
808 DRUG ADMINISTRATION ERROR 38 0.0012
809 EAR PAIN 24 0.0012
810 NEURALGIA 30 0.0012
811 CIRCULATORY COLLAPSE 21 0.0012
812 DRUG INEFFECTIVE 1610 0.0012
813 LABORATORY TEST ABNORMAL 36 0.0012
814 SKIN DISCOLOURATION 56 0.0012
815 METASTASES TO BONE 20 0.0012
816 BASAL CELL CARCINOMA 19 0.0012
817 HYPOCALCAEMIA 23 0.0012
818 VENTRICULAR TACHYCARDIA 20 0.0012
819 PNEUMONIA ASPIRATION 30 0.0012
820 COAGULOPATHY 20 0.0012
821 COGNITIVE DISORDER 56 0.0012
822 POST PROCEDURAL COMPLICATION 23 0.0012
823 SEIZURE 138 0.0012
824 PRESCRIBED OVERDOSE 23 0.0012
825 INFECTION 172 0.0012
826 DRUG EFFECT DECREASED 64 0.0012
827 BLOOD COUNT ABNORMAL 18 0.0012
828 OSTEOPENIA 18 0.0012
829 JOINT STIFFNESS 31 0.0012
830 CARDIOVASCULAR DISORDER 30 0.0012
831 PRODUCT TASTE ABNORMAL 16 0.0012
832 HIP FRACTURE 38 0.0012
833 ANOSMIA 17 0.0012
834 PERICARDIAL EFFUSION 27 0.0012
835 EMOTIONAL DISORDER 36 0.0012
836 PLEURAL EFFUSION 71 0.0012
837 APATHY 17 0.0012
838 ANAEMIA 221 0.0012
839 CONTRAINDICATED PRODUCT ADMINISTERED 35 0.0012
840 CRYING 42 0.0012
841 ANHEDONIA 30 0.0011
842 EOSINOPHILIA 20 0.0011
843 BLISTER 64 0.0011
844 RESPIRATORY FAILURE 83 0.0011
845 ABASIA 28 0.0011
846 DYSSTASIA 33 0.0011
847 LACRIMATION INCREASED 34 0.0011
848 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 80 0.0011
849 FEAR 30 0.0011
850 PNEUMONIA 361 0.0011
851 PARANOIA 19 0.0011
852 UNRESPONSIVE TO STIMULI 28 0.0011
853 HAEMATOMA 28 0.0011
854 ADVERSE EVENT 99 0.0011
855 HEPATIC FUNCTION ABNORMAL 40 0.0011
856 GENERAL PHYSICAL HEALTH DETERIORATION 124 0.0011
857 DEAFNESS 28 0.0011
858 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 50 0.0011
859 WHITE BLOOD CELL COUNT INCREASED 41 0.0011
860 EXPOSURE DURING PREGNANCY 66 0.0011
861 ERYTHEMA 218 0.0011
862 PULMONARY OEDEMA 47 0.0010
863 DRUG DISPENSING ERROR 16 0.0010
864 MENTAL STATUS CHANGES 29 0.0010
865 DEVICE RELATED INFECTION 16 0.0010
866 COLITIS ULCERATIVE 46 0.0010
867 PALLOR 28 0.0010
868 CHOKING 20 0.0010
869 LIVER INJURY 25 0.0010
870 C-REACTIVE PROTEIN INCREASED 37 0.0010
871 PYREXIA 351 0.0010
872 DELIRIUM 35 0.0010
873 PULMONARY HYPERTENSION 21 0.0010
874 CLOSTRIDIUM DIFFICILE INFECTION 22 0.0010
875 RESPIRATORY TRACT CONGESTION 16 0.0010
876 FULL BLOOD COUNT DECREASED 20 0.0010
877 PELVIC PAIN 18 0.0010
878 LOWER RESPIRATORY TRACT INFECTION 45 0.0010
879 MATERNAL EXPOSURE DURING PREGNANCY 88 0.0010
880 ANGER 33 0.0010
881 SKIN CANCER 21 0.0010
882 AMENORRHOEA 17 0.0010
883 HALLUCINATION 73 0.0010
884 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 53 0.0010
885 DRUG ERUPTION 17 0.0010
886 EYE PAIN 54 0.0010
887 PHOTOPHOBIA 18 0.0010
888 ECZEMA 50 0.0010
889 MUSCULOSKELETAL DISORDER 18 0.0009
890 RASH MACULO-PAPULAR 21 0.0009
891 OSTEONECROSIS 31 0.0009
892 BRADYCARDIA 50 0.0009
893 THERAPEUTIC RESPONSE DECREASED 57 0.0009
894 BONE PAIN 55 0.0009
895 AGITATION 68 0.0009
896 EYE PRURITUS 31 0.0009
897 ORAL HERPES 18 0.0009
898 EPILEPSY 28 0.0009
899 THERAPEUTIC PRODUCT EFFECT DECREASED 41 0.0009
900 ACTIVITIES OF DAILY LIVING IMPAIRED 18 0.0009
901 MELAENA 20 0.0009
902 PRODUCT COMPLAINT 23 0.0009
903 STOMATITIS 55 0.0009
904 SKIN DISORDER 30 0.0009
905 INCORRECT ROUTE OF DRUG ADMINISTRATION 32 0.0009
906 PRODUCT PHYSICAL ISSUE 18 0.0009
907 RASH MACULAR 31 0.0009
908 RHEUMATOID ARTHRITIS 99 0.0009
909 ABNORMAL DREAMS 24 0.0009
910 PRODUCT SUBSTITUTION ISSUE 50 0.0009
911 OCULAR HYPERAEMIA 41 0.0009
912 DRY EYE 43 0.0009
913 DERMATITIS 18 0.0009
914 TOOTH DISORDER 19 0.0009
915 RED BLOOD CELL COUNT DECREASED 24 0.0008
916 PRODUCT AVAILABILITY ISSUE 19 0.0008
917 APHASIA 25 0.0008
918 TOOTH LOSS 17 0.0008
919 BLOOD BILIRUBIN INCREASED 22 0.0008
920 MOUTH ULCERATION 17 0.0008
921 RENAL CANCER 38 0.0008
922 GASTRIC CANCER 20 0.0008
923 BONE MARROW FAILURE 16 0.0008
924 INCORRECT PRODUCT ADMINISTRATION DURATION 17 0.0008
925 BODY TEMPERATURE INCREASED 16 0.0008
926 JOINT SWELLING 94 0.0008
927 PAIN IN JAW 22 0.0008
928 SUICIDE ATTEMPT 47 0.0008
929 NERVOUS SYSTEM DISORDER 24 0.0008
930 GLOSSODYNIA 17 0.0008
931 RASH PAPULAR 17 0.0008
932 MENSTRUATION IRREGULAR 20 0.0007
933 MEDICATION ERROR 41 0.0007
934 RASH ERYTHEMATOUS 35 0.0007
935 ABNORMAL BEHAVIOUR 29 0.0007
936 LUNG NEOPLASM MALIGNANT 30 0.0007
937 DEVICE DIFFICULT TO USE 48 0.0007
938 RESPIRATORY DISTRESS 20 0.0007
939 HAEMORRHAGE 75 0.0007
940 THERAPY INTERRUPTED 51 0.0007
941 INCORRECT DRUG ADMINISTRATION DURATION 20 0.0007
942 PSYCHOTIC DISORDER 21 0.0007
943 PAIN OF SKIN 19 0.0007
944 MENTAL IMPAIRMENT 17 0.0007
945 MUSCLE TWITCHING 16 0.0007
946 DYSKINESIA 28 0.0007
947 DEPRESSED LEVEL OF CONSCIOUSNESS 27 0.0007
948 FOETAL EXPOSURE DURING PREGNANCY 55 0.0007
949 WITHDRAWAL SYNDROME 28 0.0007
950 INFUSION RELATED REACTION 44 0.0007
951 HAEMOGLOBIN DECREASED 68 0.0007
952 DRY SKIN 88 0.0007
953 SKIN IRRITATION 30 0.0007
954 MOVEMENT DISORDER 21 0.0007
955 PLATELET COUNT DECREASED 69 0.0006
956 FEMUR FRACTURE 20 0.0006
957 AGGRESSION 32 0.0006
958 INTENTIONAL OVERDOSE 41 0.0006
959 THERAPEUTIC RESPONSE SHORTENED 21 0.0006
960 NEOPLASM PROGRESSION 22 0.0006
961 ACNE 47 0.0006
962 SYSTEMIC LUPUS ERYTHEMATOSUS 22 0.0006
963 PANCYTOPENIA 34 0.0006
964 BONE DENSITY DECREASED 19 0.0006
965 SKIN BURNING SENSATION 41 0.0006
966 DERMATITIS ATOPIC 30 0.0006
967 THERAPY NON-RESPONDER 25 0.0006
968 OVERDOSE 118 0.0005
969 MULTIPLE SCLEROSIS 26 0.0005
970 THROMBOCYTOPENIA 58 0.0005
971 DEATH 446 0.0005
972 INTERSTITIAL LUNG DISEASE 25 0.0005
973 DISEASE RECURRENCE 24 0.0005
974 ACCIDENTAL EXPOSURE TO PRODUCT 51 0.0005
975 PLASMA CELL MYELOMA 19 0.0005
976 MULTIPLE SCLEROSIS RELAPSE 33 0.0005
977 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 16 0.0005
978 INJURY 32 0.0005
979 PROSTATE CANCER 36 0.0004
980 ELECTROCARDIOGRAM QT PROLONGED 16 0.0004
981 EYE IRRITATION 25 0.0004
982 TOXICITY TO VARIOUS AGENTS 69 0.0004
983 TREATMENT FAILURE 33 0.0004
984 DRUG WITHDRAWAL SYNDROME 31 0.0004
985 WHITE BLOOD CELL COUNT DECREASED 38 0.0004
986 COMPLETED SUICIDE 29 0.0003
987 DISEASE PROGRESSION 41 0.0003
988 CONVULSION 18 0.0003
989 NEUTROPENIA 40 0.0003
990 MALIGNANT NEOPLASM PROGRESSION 30 0.0003
991 DRUG DEPENDENCE 41 0.0003